651 filings
Page 16 of 33
8-K
w610l0d yz6t
9 May 16
Aviragen Therapeutics Reports Third Quarter Fiscal Year 2016 Financial Results
12:00am
8-K
624ra7kao05 62q
26 Apr 16
Aviragen Therapeuticscompletes Royaltydealwith Healthcare Royalty Partners Forproceeds of $20 Million
12:00am
8-K
lhup7
13 Apr 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
1y47o
11 Apr 16
Biota Initiates Phase 2A Efficacy Study of BTA585 for the Treatment of RSV Infections
12:00am
8-K
zldt29e
24 Mar 16
Changes in Registrant's Certifying Accountant
12:00am
8-K
50em037f kq
26 Feb 16
Biota Announces Positive Results from Phase 1 Program for Direct
12:00am
8-K
bgbnp5g 77
17 Feb 16
Other Events
12:00am
8-K
0bspi3z5qn01jeh
12 Feb 16
Material Modifications to Rights of Security Holders
12:00am
8-K
0s07jek cuh52
5 Feb 16
Biota Pharmaceuticals Reportssecond Quarter
12:00am
8-K
gemdqpk9
18 Dec 15
Other Events
12:00am
8-K
nb1cwo4x3 qaqdyqq
12 Nov 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
4ewj18l
6 Nov 15
Biota Pharmaceuticals Reportsfirst Quarter
12:00am
8-K
9j0cnbbdtopf3agu
2 Nov 15
Biota Pharmaceuticalsannounces Appointment Ofmark P. Colonnese As Chief Financial Officer
12:00am
ARS
2x7i6
14 Oct 15
Annual report to shareholders
12:00am
424B5
bj2nsc 1s7xfqyopht6
2 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
yr50z pxiq08e3
2 Oct 15
Entry into a Material Definitive Agreement
12:00am